Pharma Foods International (2929) · RiskMitigated
Dependence on the Representative Director
First written in FY2019. 1 of 2 entries say "Mitigated", first in FY2021. Latest entry: FY2021.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Dependence on key executivesA theme 560 companies write about · 560 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2026: 10 of 77 companies on the "Worse" side.
13 other companies' latest entry also says "Mitigated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 560 threads.Full recordFilings, disclosures and news, newest first
- FY2021MitigatedAnnual report
「To avoid excessive dependence on this individual, the Group has been strengthening its organizational response, delegating authority, and expanding its workforce. However, if, for any reason, this individual becomes unable to perform his duties, some of the Group’s business operations may be disrupted.」
While continuing to disclose the risk of dependence on the Representative Director, the Company specified measures to reduce that dependence through delegation of authority and workforce expansion. - FY2019First statedAnnual report
「The Group is highly dependent on this individual. If, for any reason, this individual becomes unable to perform his duties, the Group’s business operations and other activities may be seriously disrupted.」
The Representative Director and President plays an important role through management policy and business strategy, personal networks, and sales capabilities, and the potential impact on business operations if he becomes unable to perform his duties has been disclosed as a risk.